AI blood test aims to pinpoint breast cancer spread
NCT ID NCT07304934
Summary
This study is testing a new AI-powered blood test to see how accurately it can determine the stage of breast cancer, specifically whether it has spread to lymph nodes. Researchers will collect blood samples from 269 people with breast cancer, some having surgery directly and others receiving drug treatment first. The goal is to see if this 'liquid biopsy' can match or improve upon current methods for staging the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.